Q4 2024 Earnings Call Transcript November 4, 2024 Hologic, Inc. reports earnings inline with expectations. Reported EPS is $1 ...

Good afternoon, and welcome to the Hologic's Fourth Quarter Fiscal 2024 Earnings Conference Call. My name is Shelly, and I am your operator for today’s call. Today's conference is being recorded. All ...

Hologic (HOLX – Research Report), the Healthcare sector company, was revisited by a Wall Street analyst yesterday. Analyst Tejas Savant ...

Hologic Inc (HOLX) announced a profit for its fourth quarter that increased from the same period last year in line with the Street ...

For the current quarter ending in December, Hologic expects its per-share earnings to range from $1 to $1.03. The company said it expects revenue in the range of $1.02 billion to $1.03 billion for the ...

IFM Investors Pty Ltd raised its stake in Hologic, Inc. (NASDAQ:HOLX – Free Report) by 2.7% in the 3rd quarter, according to ...

Hologic, Inc. focuses on women's health, projecting $4 billion in revenue for 2024. Learn why HOLX stock remains a compelling ...

The agency is alerting patients and providers to not use the implantable devices, made for soft tissue such as breast tissue.

Hologic, Inc. has a 52 week low of $64.02 and a 52 week high of $84.67. The stock has a market cap of $18.77 billion, a price-to-earnings ratio of 27.49, a PEG ratio of 2.96 and a beta of 0.98.

FDA and Hologic advise health providers to return all unused BioZorb Markers due to adverse events, including pain and ...

Hologic, Inc. HOLX reported adjusted earnings per share (EPS) of $1.01 in the fourth quarter of fiscal 2024, up 13.5% year ...

Shares of Hologic Inc. HOLX slipped 0.46% to $80.46 Monday, on what proved to be an all-around great trading session for the stock market, with the S&P 500 Index SPX rising 0.27% to 5,823.52 and ...